4Mota J, Acosta M , Argotte R. Induction of protective antibodies against dengue virus by tetravalent DNA immunization of mice with domain Ⅲof the envelope protein [ J ]. Vaccine, 2005 (26) : 3469 - 3476.
5Moreno-Ahamirano, M. M. B. , Sanchez-Garcia. , et al. Non Fc receptor -mediated infection of human macrophages by dengue virus serotype 2[J]. J Gen Virol,2002( 83 ) :1123 - 1130.
6Jan JH, Meng TH, Ming J Y, et al. An external loop region of domain Ⅲ of dengue virus type 2 envelope protein is involved insero type 2 specific binding to mosquito but not mammalian cells [ J ]. J Virol,2004 ( 1 ) :382 - 388.
7Screaton G, Mongkolsapaya J. T cell responses and dengue haemorrhagic fever [J ]. Novartis Found Symp, 2006 (277) :164 - 171.
8Jaiswal S, Khanna N, Swaminathan S. High-level expression and one step purification of recombinant dengue virus type 2 envelope domain Ⅲ protein in Escherichia coli [ J ]. Protein Expr Purif, 2004 ( 33 ) : 80 - 91.
9Guy B, Chanthavanich P, Gimenez S, et al. Evaluation by filow cytometry of antibody-dependent enhancement (ADE) of dengue infection by sera from Thai children immunized with a live-auenuaed tetravalent dengue vaccine [ J ]. Vaccine,2004 (27 - 28 ) : 3563 - 3574.
10Roehrig JT, Volpe KE, Squires J. Contribution of disulfide bridging to epltope expression of the dengue type 2 virus envelope glycoprotein [ J ]. J Virol, 2004 ( 781 ) : 2648 - 2652.
